Pragma Bio discovers new medicines using a biology-first approach that mines clinically-relevant sources of novel small molecules targeting the gut-immune axis for various clinical applications.
peer of
competitor of
Metrics
marketPRIVATE
msh_idCOM:PRAGMABIO
localeus
websitehttps://www.pragmabio.com/
source_ref5be0924c-b0e1-49d5-8ecd-a35aeed2ca34
products_or_servicesAI-enabled platform for discovering and developing gut-derived small molecules for therapeutic use in managing immune-related health conditions.
United States